Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TMXLU:LX

29.4600 USD 0.3200 1.10%

As of 03:48:28 ET on 01/30/2015.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TMXLU)

Open: 29.4600 High - Low: 29.4600 - 29.4600 Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 19.8100 - 29.8200 Beta vs NBI: 0.9457

ETF Chart for TMXLU

No chart data available.
  • TMXLU:LX 29.4600
  • 1D
  • 1M
  • 1Y
29.1400
Interactive TMXLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TMXLU

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.lu

Fundamentals for TMXLU

NAV -
Assets (M) (on 2014-12-31) 2,529.8680
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for TMXLU

No dividends reported

Performance for TMXLU

1-Month +5.67% 1-Year +24.78%
3-Month +8.51% 3-Year +37.79%
Year To Date +5.67% 5-Year +29.14%
Expense Ratio 2.71

Top Fund Holdings for TMXLU

Filing Date: 10/31/2014
Name Position Value % of Total
Celgene Corp 2,424,900 259,682,541 10.304%
Gilead Sciences Inc 1,917,000 214,704,000 8.519%
Biogen Idec Inc 538,940 173,042,855 6.866%
Amgen Inc 879,200 142,588,656 5.658%
Medivation Inc 927,800 98,068,460 3.891%
Regeneron Pharmaceuticals Inc 207,000 81,500,040 3.234%
Illumina Inc 408,600 78,688,188 3.122%
Incyte Corp 1,111,400 74,530,484 2.957%
BioMarin Pharmaceutical Inc 821,595 67,781,588 2.690%
Alexion Pharmaceuticals Inc 353,800 67,703,168 2.686%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil